LUMC researchers and French colleagues have developed a new technique to see and measure the brain's smallest blood vessels for the first time. This breakthrough could enable earlier detection and treatment of neurological and hereditary diseases like Alzheimer's, Parkinson's, HHT, CADASIL, and RVCL-S, possibly before irreversible brain damage occurs. It opens the door to treatments that act before diseases fully develop.
Read more